title: Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.
abstract: Benzodiazepine withdrawal anxiety is associated with potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR) currents in hippocampal CA1 pyramidal neurons attributable to increased synaptic incorporation of GluA1-containing AMPARs. The contribution of calcium/calmodulin-dependent protein kinase II (CaMKII) to enhanced glutamatergic synaptic strength during withdrawal from 1-week oral flurazepam (FZP) administration was further examined in hippocampal slices. As earlier reported, AMPAR-mediated miniature excitatory postsynaptic current (mEPSC) amplitude increased in CA1 neurons from 1- and 2-day FZP-withdrawn rats, along with increased single-channel conductance in neurons from 2-day rats, estimated by non-stationary noise analysis. Input-output curve slope was increased without a change in paired-pulse facilitation, suggesting increased AMPAR postsynaptic efficacy rather than altered glutamate release. The increased mEPSC amplitude and AMPAR conductance were related to CaMKII activity, as intracellular inclusion of CaMKIINtide or autocamtide-2-related inhibitory peptide, but not scrambled peptide, prevented both AMPAR amplitude and conductance changes. mEPSC inhibition by 1-naphthyl acetyl spermine and the negative shift in rectification index at both withdrawal time points were consistent with functional incorporation of GluA2-lacking AMPARs. GluA1 but not GluA2 or GluA3 levels were increased in immunoblots of postsynaptic density (PSD)-enriched subcellular fractions of CA1 minislices from 1-day FZP-withdrawn rats, when mEPSC amplitude, but not conductance, was increased. Both GluA1 expression levels and CaMKII alpha-mediated GluA1 Ser(831) phosphorylation were increased in PSD-subfractions from 2-day FZP-withdrawn rats. As phospho-Thr(286)CaMKII alpha was unchanged, CaMKII alpha may be activated through an alternative signaling pathway. Synaptic insertion and subsequent CaMKII alpha-mediated Ser(831) phosphorylation of GluA1 homomers contribute to benzodiazepine withdrawal-induced AMPAR potentiation and may represent an important hippocampal pathway mediating both drug-induced and activity-dependent plasticity.
authors.affiliation: Department of Physiology and Pharmacology, University of Toledo College of Medicine, Health Science Campus, Toledo, OH 43614, USA.
authors.forename: Guofu
authors.initials: G
authors.lastname: Shen
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: Van Sickle
authors.forename: Elizabeth I
authors.initials: EI
authors.lastname: Tietz
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001569:Benzodiazepines / Q000008:administration & dosage*; D055592:Biophysical Phenomena / Q000187:drug effects; D001703:Biophysics; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000378:metabolism*; D004195:Disease Models, Animal; D004347:Drug Interactions; D004558:Electric Stimulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018683:Excitatory Amino Acid Agents / Q000494:pharmacology; D005479:Flurazepam / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D018698:Glutamic Acid / Q000378:metabolism*; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009473:Neuronal Plasticity / Q000187:drug effects*; D018408:Patch-Clamp Techniques; D017966:Pyramidal Cells / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017470:Receptors, Glutamate / Q000378:metabolism; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism; D013375:Substance Withdrawal Syndrome / Q000473:pathology / Q000503:physiopathology; D013997:Time Factors
chemical_list: D004791:Enzyme Inhibitors; D018683:Excitatory Amino Acid Agents; D006993:Hypnotics and Sedatives; D017470:Receptors, Glutamate; D001569:Benzodiazepines; D018698:Glutamic Acid; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D005479:Flurazepam
references.citation: Nat Neurosci. 1998 Sep;1(5):378-83
references.pmid: 10196527
references.citation: Curr Opin Pharmacol. 2005 Feb;5(1):47-52
references.pmid: 15661625
references.citation: Trends Neurosci. 2003 Jan;26(1):9-11
references.pmid: 12495855
references.citation: Biochem Soc Trans. 2009 Dec;37(Pt 6):1394-8
references.pmid: 19909283
references.citation: Science. 1991 May 10;252(5007):851-3
references.pmid: 1709304
references.citation: Nat Rev Neurosci. 2004 Dec;5(12):952-62
references.pmid: 15550950
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3269-74
references.pmid: 10077673
references.citation: Nat Neurosci. 2006 May;9(5):602-4
references.pmid: 16582904
references.citation: Neuropsychopharmacology. 2004 Nov;29(11):1994-2006
references.pmid: 15266351
references.citation: Nat Neurosci. 2008 Mar;11(3):344-53
references.pmid: 18278040
references.citation: Nat Neurosci. 2007 Apr;10(4):469-77
references.pmid: 17351635
references.citation: J Neurosci. 2006 Jan 25;26(4):1164-74
references.pmid: 16436603
references.citation: J Neurosci. 2008 Jun 4;28(23):6000-9
references.pmid: 18524905
references.citation: Nat Neurosci. 2003 Feb;6(2):136-43
references.pmid: 12536214
references.citation: Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):721-6
references.pmid: 12740118
references.citation: J Neurochem. 2007 Dec;103(6):2518-28
references.pmid: 17949410
references.citation: Synapse. 2009 Aug;63(8):690-7
references.pmid: 19360908
references.citation: Nat Rev Neurosci. 2007 Feb;8(2):101-13
references.pmid: 17237803
references.citation: Synapse. 2009 Mar;63(3):224-35
references.pmid: 19084907
references.citation: Exp Neurol. 2008 Apr;210(2):750-61
references.pmid: 18294632
references.citation: Eur J Neurosci. 1994 Jul 1;6(7):1080-8
references.pmid: 7524964
references.citation: Science. 2000 Mar 24;287(5461):2262-7
references.pmid: 10731148
references.citation: Pharmacology. 1997 Nov;55(5):217-27
references.pmid: 9399331
references.citation: Nat Rev Neurosci. 2002 Mar;3(3):175-90
references.pmid: 11994750
references.citation: J Physiol. 1995 Jan 15;482 ( Pt 2):325-52
references.pmid: 7536248
references.citation: Synapse. 2005 Oct;58(1):1-12
references.pmid: 16037950
references.citation: BMC Neurosci. 2004 Nov 11;5:44
references.pmid: 15538948
references.citation: Neuron. 1998 Sep;21(3):593-606
references.pmid: 9768845
references.citation: J Neurosci. 2005 Apr 6;25(14):3674-9
references.pmid: 15814798
references.citation: J Neurochem. 2009 Jul;110(1):363-77
references.pmid: 19457111
references.citation: Neuron. 2009 Apr 30;62(2):254-68
references.pmid: 19409270
references.citation: J Neurophysiol. 2010 Jan;103(1):479-89
references.pmid: 19906877
references.citation: J Biol Chem. 1997 Dec 19;272(51):32528-33
references.pmid: 9405465
references.citation: Neuropharmacology. 2002 Sep;43(4):595-606
references.pmid: 12367605
references.citation: Science. 1999 Jun 11;284(5421):1811-6
references.pmid: 10364548
references.citation: J Neurosci. 2007 May 9;27(19):5190-9
references.pmid: 17494705
references.citation: J Biol Chem. 1997 Dec 26;272(52):32727-30
references.pmid: 9407043
references.citation: J Neurosci. 2007 Apr 25;27(17):4598-602
references.pmid: 17460072
references.citation: Synapse. 1995 Dec;21(4):289-98
references.pmid: 8869159
references.citation: J Neurosci. 2003 Oct 15;23(28):9367-73
references.pmid: 14561864
references.citation: Science. 1997 Jun 27;276(5321):2042-5
references.pmid: 9197267
references.citation: Nature. 2001 Jun 14;411(6839):801-5
references.pmid: 11459059
references.citation: J Neurosci. 1996 Mar 15;16(6):1982-9
references.pmid: 8604042
references.citation: Behav Pharmacol. 2007 Sep;18(5-6):447-60
references.pmid: 17762513
references.citation: J Comp Neurol. 2003 Jul 14;462(1):15-28
references.pmid: 12761821
references.citation: J Neurosci. 2005 Oct 5;25(40):9144-51
references.pmid: 16207873
references.citation: J Neurosci. 2002 Jun 1;22(11):4406-11
references.pmid: 12040047
references.citation: Neuropharmacology. 2009 Jan;56(1):2-5
references.pmid: 18655795
references.citation: Neuropharmacology. 2002 Jul;43(1):11-27
references.pmid: 12213255
references.citation: Biochem Biophys Res Commun. 2006 Jul 14;345(4):1606-10
references.pmid: 16730662
references.citation: J Physiol. 2006 Jun 1;573(Pt 2):371-94
references.pmid: 16527860
references.citation: Psychopharmacology (Berl). 1998 Apr;136(3):308-10
references.pmid: 9566818
references.citation: Nat Neurosci. 2005 Jul;8(7):853-4
references.pmid: 15924137
references.citation: J Neurosci. 2010 Jan 20;30(3):939-49
references.pmid: 20089902
references.citation: J Pharmacol Exp Ther. 2007 Aug;322(2):569-81
references.pmid: 17510319
references.citation: Nature. 2003 Jan 2;421(6918):70-5
references.pmid: 12511956
references.citation: J Neurosci. 1996 Jan;16(1):274-82
references.pmid: 8613793
references.citation: J Pharmacol Exp Ther. 2008 Dec;327(3):872-83
references.pmid: 18812492
references.citation: Biochem Biophys Res Commun. 1995 Jul 26;212(3):806-12
references.pmid: 7626114
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3483-8
references.pmid: 11248104
references.citation: Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11175-9
references.pmid: 7479960
references.citation: J Pharmacol Exp Ther. 1996 Aug;278(2):669-78
references.pmid: 8768718
references.citation: Neuropharmacology. 2004;47 Suppl 1:61-79
references.pmid: 15464126
references.citation: Neuron. 2004 Sep 30;44(1):75-91
references.pmid: 15450161
references.citation: Nat Rev Neurosci. 2007 Nov;8(11):844-58
references.pmid: 17948030
references.citation: Neuroscience. 2009 Mar 3;159(1):414-26
references.pmid: 19105975
references.citation: J Neurosci. 1997 Jan 1;17(1):58-69
references.pmid: 8987736
references.citation: Nature. 1998 Jun 25;393(6687):793-7
references.pmid: 9655394
references.citation: Curr Pharm Des. 2002;8(1):5-21
references.pmid: 11812247
references.citation: J Clin Psychiatry. 2005;66 Suppl 9:31-41
references.pmid: 16336040
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20033-8
references.pmid: 19892736
references.citation: Nature. 1997 Dec 11;390(6660):607-11
references.pmid: 9403689
references.citation: Synapse. 1999 Mar 15;31(4):263-77
references.pmid: 10051107
references.citation: Nat Neurosci. 2000 Nov;3(11):1098-106
references.pmid: 11036266
references.citation: Pharmacol Ther. 2003 May;98(2):171-95
references.pmid: 12725868
references.citation: J Comp Neurol. 2010 Nov 1;518(21):4311-28
references.pmid: 20853509
references.citation: Neuron. 1995 Aug;15(2):443-52
references.pmid: 7646896
references.citation: J Neurochem. 1996 Jan;66(1):1-5
references.pmid: 8522940
references.citation: J Comp Neurol. 2008 Dec 20;511(6):832-46
references.pmid: 18924138
references.citation: Proc Natl Acad Sci U S A. 1985 May;82(9):3035-9
references.pmid: 2859595